Key Takeaways Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for ...
A recent study provided key insights into brain degeneration in DLB, which may help clinicians better monitor this ...
The University of Massachusetts Lowell, Department of Chemistry, invites you to attend a Master’s Thesis defense by Madelyn Hallisey on “Novel PET Radiochemistry: Adapting Analytical and ...
The Alzheimer’s Disease Research Center (ADRC) at the University of Pittsburgh is one of the country’s hubs for researchers ...
In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker ...
Medical Device Network on MSN5d
Telix’s prostate cancer imaging agent approved in BrazilBrazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
Through close collaboration between United Imaging and Papapostolou Healthcare Technologies, a provider of high-tech medical ...
Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...
After being diagnosed with advanced stage melanoma, Tash Sutton is on a mission to help others avoid the same fate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback